Acrivon AB vs LifeMine Therapeutics Inc.
Acrivon AB vs LifeMine Therapeutics Inc., compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Acrivon AB is on 43/100 and LifeMine Therapeutics Inc. on 60/100.
Where each one leads
Acrivon AB
- agent readiness: 40/100 against 21/100
LifeMine Therapeutics Inc.
- our overall score: 60/100 against 43/100
- funding raised: $543M against $10.0M
At a glance
| Measure | Acrivon AB | LifeMine Therapeutics Inc. |
|---|---|---|
| What it is | Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. | Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi. |
| Category | AI Tools & Apps, AI Drug Discovery, Biotech, HealthTech | Biotechnology, Drug Discovery, Therapeutics, Immunology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2022 | 2017 |
| Headquarters | Uppsala, Sweden | Watertown, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Acrivon AB | LifeMine Therapeutics Inc. |
|---|---|---|
| Employees | Not published | 31 |
| Total funding | $10.0M | $543M |
| Latest round | Seed | Funding Round |
| LinkedIn followers | Not published | 13,190 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Acrivon AB | LifeMine Therapeutics Inc. |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 60/100 |
| Traction | 35/100 | 55/100 |
| Team | 60/100 | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 5/100 | 20/100 |
| Quality | 50/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 30/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Acrivon AB | LifeMine Therapeutics Inc. |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | React | Tailwind CSS |
| Analytics | Google Analytics 4 | Not detected |
Acrivon AB vs LifeMine Therapeutics Inc.: common questions
Which is better, Acrivon AB or LifeMine Therapeutics Inc.?
On our 0-100 score LifeMine Therapeutics Inc. rates higher (60/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Acrivon AB and LifeMine Therapeutics Inc. compare on the numbers?
Acrivon AB leads on agent readiness (40/100 against 21/100). LifeMine Therapeutics Inc. leads on our overall score (60/100 against 43/100), funding raised ($543M against $10.0M).
Read the full Acrivon AB review and pricing or the LifeMine Therapeutics Inc. review and pricing. You can also browse other Acrivon AB alternatives we track.